Verona Pharma plc ( VRNA) - Stock Earnings
Stock symbol VRNA is outdated, potentially delisted? Maybe it is available on other exchange?
VRNA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -33.8 million USD | 36.7 million USD |
| 2025Q1 | -16.3 million USD | 76.3 million USD |
| 2025Q2 | 11.9 million USD | 103.1 million USD |
VRNA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -68.7 million USD | 458000 USD |
| 2023 | -54.4 million USD | 458000 USD |
| 2024 | -173.4 million USD | 42.3 million USD |
VRNA
Price: $106.91
52 week price:
Earnings Per Share: -1.04 USD
P/E Ratio: -102.70
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 555000
Ebitda: -10.7 millionMarket Capitalization: 9.1 billion